Palisade Bio Inc. buy Brookline Capital Management
Start price
20.11.24
/
50%
€0.34
Target price
20.11.25
€36.03
Performance (%)
-
End price
21.11.25
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Palisade Bio Inc. | - | - | - |
| iShares Core DAX® | 4,57 % | 4,14 % | 7,35 % |
| iShares Nasdaq 100 | 1,83 % | -1,64 % | 33,64 % |
| iShares Nikkei 225® | -0,29 % | 2,47 % | 60,45 % |
| iShares S&P 500 | 2,23 % | 0,71 % | 24,13 % |
Comments by Brookline_Capital_Ma for this prediction
In the thread Trading Palisade Bio Inc.
Die von Brookline_Capital_Ma gewählte maximale Laufzeit wurde überschritten
In the thread Palisade Bio Inc. diskutieren
Palisade Bio, Inc. (NASDAQ: PALI) is now covered by analysts at Brookline Capital Management. They set a "buy" rating and a $38.00 price target on the stock.
Ratings data for PALI provided by MarketBeat